Rayca Precision will be attending Nordic Life Science Days in Stockholm from 8 to 9 September 2026.

Rayca Precision is an AI-native operating system for drug development, built to break the silos that pharma R&D runs on, where the data already scattered across a pipeline is reconnected and put back to work, and where the walls between discovery and development come down. Held in one place and compounding across programs, that becomes a collective intelligence for how the world makes medicine. Faster to the clinic. Cheaper per cure. More diseases in reach. Drug development has no memory, and that is its most expensive flaw. Rayca pulls developability, delivery, and formulation forward into design. Our agentic engine carries a program from target to candidate, pairs generative design with physics-based simulation, models targets as conformational ensembles, and surfaces the cryptic and allosteric pockets that make hard targets tractable.